Precision Medicine company Progenity, a developer of both diagnostic and therapeutic platforms, announced results from three studies that represent potential breakthrough methods for diagnosing, treating, and monitoring digestive diseases through ingestible technologies. The studies, which encompass both human and preclinical models, showed that the company's ingestible diagnostic capsule ....